Noa G. Holtzman, M.D.

Noa G. Holtzman, M.D.
Assistant Research Physician

Dr. Holtzman's main research interests include hematopoietic stem cell transplantation (HSCT) for hematologic malignancies with a focus on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), graft-versus-host disease (GVHD), improving post-transplant outcomes, and cellular immunotherapy.

Areas of Expertise

1) hematopoietic stem cell transplantation, 2) graft-versus-host disease, 3) hematologic malignancies, 4) myelodysplastic syndromes, 5) acute myeloid leukemia, 6) cellular therapy

Contact Info

Noa G. Holtzman, M.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room 12C-434
Bethesda, MD 20892
Ph: 240-858-3224

Dr. Holtzman is involved in clinical research focused on improving post-HSCT outcomes for hematologic malignancy patients, including immunomodulatory strategies for prevention of post-HSCT relapse. She is active in clinical trials evaluating JAK inhibitors and other new agents for treatment of refractory chronic GVHD on the team led by Dr. Steven Pavletic. Dr. Holtzman is also involved in the implementation of several clinical trial protocols for treatment of MDS under the new NIH myeloid malignancies program.

NIH Scientific Focus Areas:
Cancer Biology, Clinical Research, Immunology
View Dr. Holtzman's PubMed Summary

Selected Recent Publications

  1. Holtzman NG, Xie H, Bentzen S, Kesari V, Bukhari A, El Chaer F, Lutfi F, Siglin J, Hutnick E, Gahres N, Ruehle K, Ahmad H, Shanholtz C, Kocoglu MH, Badros AZ, Yared JA, Hardy NM, Rapoport AP, Dahiya S.
    Neuro Oncol. Epub ahead of print (Aug. 5), 2020. [ Journal Article ]
  2. Goklemez S, Im AP, Cao L, Pirsl F, Steinberg SM, Curtis LM, Mitchell SA, Cowen EW, Baruffaldi J, Rose J, Mays J, Ostojic A, Holtzman NG, Hakim FT, Pavletic SZ.
    Am J Hematol. Epub ahead of print (Jan. 5), 2020. [ Journal Article ]
  3. Holtzman NG, El Chaer F, Baer MR, Ali O, Patel A, Duong VH, Sausville EA, Singh ZN, Koka R, Zou YS, Etemadi A, Emadi A.
    Br J Haematol. 188(6): 881-887, 2020. [ Journal Article ]
  4. Bathini S, Holtzman NG, Koka R, Singh Z, Wilding E, Zou Y, Ruehle K, Kocoglu MH, Badros A, Hardy N, Yared J, Rapoport AP, Fontaine M, Emadi A, El Chaer F, Dahiya S.
    Am J Hematol. 94(8): E216-E219, 2019. [ Journal Article ]
  5. Holtzman NG, Rapoport AP.
    Blood. 129(17): 2335-2336, 2017. [ Journal Article ]

Dr. Holtzman earned a B.A. in Biological Sciences from Cornell University in 2009 and received her M.D. from Jefferson Medical College in 2013. She then completed internal medicine residency training in 2016 and a fellowship in hematology/oncology with a sub-fellowship focus in bone marrow transplantation and cellular therapy in 2019 at the University of Maryland Medical Center. Dr. Holtzman is triple board-certified in internal medicine, hematology, and medical oncology.